ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force …

SC Smith Jr, TE Feldman, JW Hirshfeld Jr… - Journal of the American …, 2006 - Elsevier
The ACC/AHA Task Force on Practice Guidelines was formed to gather information and
make recommendations about appropriate use of technology for the diagnosis and …

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II

TF Lüscher, MA Creager, JA Beckman, F Cosentino - Circulation, 2003 - Am Heart Assoc
Diabetes and Vascular Disease | Circulation Science Volunteer Warning signs SearchSearch
Advanced Search Donate Circulation logo Hello Guest! MY ALERTS SIGN IN JOIN …

Guidelines for percutaneous coronary interventions: the Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology

S Silber, P Albertsson, FF Avilés… - European heart …, 2005 - academic.oup.com
In patients with stable CAD, PCI can be considered a valuable initial mode of
revascularization in all patients with objective large ischaemia in the presence of almost …

Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic …

SD Wiviott, E Braunwald, DJ Angiolillo, S Meisel… - Circulation, 2008 - Am Heart Assoc
Background—Patients with diabetes mellitus (DM) are at high risk for recurrent
cardiovascular events after acute coronary syndromes, in part because of increased platelet …

Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

C Patrono, B Coller, GA FitzGerald, J Hirsh, G Roth - Chest, 2004 - Elsevier
This article discusses platelet active drugs as part of the Seventh American College of Chest
Physicians Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based …

Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction

G Montalescot, P Barragan, O Wittenberg… - … England Journal of …, 2001 - Mass Medical Soc
Background When administered in conjunction with primary coronary stenting for the
treatment of acute myocardial infarction, a platelet glycoprotein IIb/IIIa inhibitor may provide …

Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus

PR Moreno, AM Murcia, IF Palacios, MN Leon… - Circulation, 2000 - Am Heart Assoc
Background—Lipid-rich, inflamed atherosclerotic lesions are associated with plaque rupture
and thrombosis, which are the most important causes of death in patients with diabetes …

[HTML][HTML] Acute coronary syndromes in diabetic patients, outcome, revascularization, and antithrombotic therapy

EE Babes, C Bustea, T Behl, MM Abdel-Daim… - Biomedicine & …, 2022 - Elsevier
Diabetes exacerbates the progression of atherosclerosis and is associated with increased
risk of developing acute coronary syndrome (ACS). Approximatively 25–30% of patients …

Implications of diabetes in patients with acute coronary syndromes: the Global Registry of Acute Coronary Events

K Franklin, RJ Goldberg, F Spencer… - Archives of Internal …, 2004 - jamanetwork.com
Background There are limited data describing the presenting characteristics, management,
and outcomes of diabetic and nondiabetic patients with an acute coronary syndrome (ACS) …

Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus

DL Bhatt, SP Marso, AT Hirsch, PA Ringleb… - American Journal of …, 2002 - ajconline.org
Following an ischemic event, diabetic patients have a higher rate of recurrence than patients
without diabetes mellitus. 1–6 Patients with diabetes but without prior myocardial infarction …